Emerging Markets Regulatory Tracker: Australia (Vol. 4 No. 57)
This article was originally published in PharmAsia News
Executive Summary
Australia’s Therapeutic Good Administration has announced a broad re-structuring of its internal structure as part of a government effort to curb costs.